Publications

Found 27 results
Author Title Type [ Year(Asc)]
Filters: Author is Thomson, James A  [Clear All Filters]
2016
Chan SSun-Kin, Hagen HR, Swanson SA, Stewart R, Boll KA, Aho J, Thomson JA, Kyba M.  2016.  Development of Bipotent Cardiac/Skeletal Myogenic Progenitors from MESP1+ Mesoderm.. Stem Cell Reports. 6(1):26-34.
D'Souza SS, Maufort J, Kumar A, Zhang J, Smuga-Otto K, Thomson JA, Slukvin II.  2016.  GSK3β Inhibition Promotes Efficient Myeloid and Lymphoid Hematopoiesis from Non-human Primate-Induced Pluripotent Stem Cells.. Stem Cell Reports. 6(2):243-56.
Lalit PA, Salick MR, Nelson DO, Squirrell JM, Shafer CM, Patel NG, Saeed I, Schmuck EG, Markandeya YS, Wong R et al..  2016.  Lineage Reprogramming of Fibroblasts into Proliferative Induced Cardiac Progenitor Cells by Defined Factors.. Cell Stem Cell. 18(3):354-67.
Leng N, Choi J, Chu L-F, Thomson JA, Kendziorski C, Stewart R.  2016.  OEFinder: a user interface to identify and visualize ordering effects in single-cell RNA-seq data.. Bioinformatics.
Zanotelli MR, Ardalani H, Zhang J, Hou Z, Nguyen EH, Swanson S, Nguyen BKim, Bolin J, Elwell A, Bischel LL et al..  2016.  Stable engineered vascular networks from human induced pluripotent stem cell-derived endothelial cells cultured in synthetic hydrogels.. Acta Biomater. 35:32-41.
2015
Cho M, Oh SSoo, Nie J, Stewart R, Radeke MJ, Eisenstein M, Coffey PJ, Thomson JA, H Soh T.  2015.  Array-based discovery of aptamer pairs.. Anal Chem. 87(1):821-8.
Hou Z, Meyer S, Propson NE, Nie J, Jiang P, Stewart R, Thomson JA.  2015.  Characterization and target identification of a DNA aptamer that labels pluripotent stem cells.. Cell Res. 25(3):390-3.
Dixon JR, Jung I, Selvaraj S, Shen Y, Antosiewicz-Bourget JE, Lee AYoung, Ye Z, Kim A, Rajagopal N, Xie W et al..  2015.  Chromatin architecture reorganization during stem cell differentiation.. Nature. 518(7539):331-6.
Hou Z, Jiang P, Swanson SA, Elwell AL, Nguyen BKim S, Bolin JM, Stewart R, Thomson JA.  2015.  A cost-effective RNA sequencing protocol for large-scale gene expression studies.. Sci Rep. 5:9570.
Yamniuk AP, Newitt JA, Doyle ML, Arisaka F, Giannetti AM, Hensley P, Myszka DG, Schwarz FP, Thomson JA, Eisenstein E.  2015.  Development of a Model Protein Interaction Pair as a Benchmarking Tool for the Quantitative Analysis of 2-Site Protein-Protein Interactions.. J Biomol Tech. 26(4):125-41.
Leng N, Li Y, McIntosh BE, Nguyen BKim, Duffin B, Tian S, Thomson JA, Dewey CN, Stewart R, Kendziorski C.  2015.  EBSeq-HMM: a Bayesian approach for identifying gene-expression changes in ordered RNA-seq experiments.. Bioinformatics. 31(16):2614-22.
Friend K, Brooks HA, Propson NE, Thomson JA, Kimble J.  2015.  Embryonic Stem Cell Growth Factors Regulate eIF2α Phosphorylation.. PLoS One. 10(9):e0139076.
Pellett S, Schwartz MP, Tepp WH, Josephson R, Scherf JM, Pier CL, Thomson JA, Murphy WL, Johnson EA.  2015.  Human Induced Pluripotent Stem Cell Derived Neuronal Cells Cultured on Chemically-Defined Hydrogels for Sensitive In Vitro Detection of Botulinum Neurotoxin.. Sci Rep. 5:14566.
Schwartz MP, Hou Z, Propson NE, Zhang J, Engstrom CJ, Costa VSantos, Jiang P, Nguyen BKim, Bolin JM, Daly W et al..  2015.  Human pluripotent stem cell-derived neural constructs for predicting neural toxicity.. Proc Natl Acad Sci U S A. 112(40):12516-21.
McIntosh BE, Brown ME, Duffin BM, Maufort JP, Vereide DT, Slukvin II, Thomson JA.  2015.  Nonirradiated NOD,B6.SCID Il2rγ-/- Kit(W41/W41) (NBSGW) mice support multilineage engraftment of human hematopoietic cells.. Stem Cell Reports. 4(2):171-80.
Tomlinson BK, Thomson JA, Bomalaski JS, Diaz M, Akande T, Mahaffey N, Li T, Dutia MP, Kelly K, Gong I-Y et al..  2015.  Phase I Trial of Arginine Deprivation Therapy with ADI-PEG 20 Plus Docetaxel in Patients with Advanced Malignant Solid Tumors.. Clin Cancer Res. 21(11):2480-6.
Raval KK, Tao R, White BE, De Lange WJ, Koonce CH, Yu J, Kishnani PS, Thomson JA, Mosher DF, Ralphe JC et al..  2015.  Pompe disease results in a Golgi-based glycosylation deficit in human induced pluripotent stem cell-derived cardiomyocytes.. J Biol Chem. 290(5):3121-36.
Howden SE, Maufort JP, Duffin BM, Elefanty AG, Stanley EG, Thomson JA.  2015.  Simultaneous Reprogramming and Gene Correction of Patient Fibroblasts.. Stem Cell Reports. 5(6):1109-18.
2014
Elcheva I, Brok-Volchanskaya V, Kumar A, Liu P, Lee J-H, Tong L, Vodyanik M, Swanson S, Stewart R, Kyba M et al..  2014.  Direct induction of haematoendothelial programs in human pluripotent stem cells by transcriptional regulators.. Nat Commun. 5:4372.
McAlpine JA, Lu H-T, Wu KC, Knowles SK, Thomson JA.  2014.  Down-regulation of argininosuccinate synthetase is associated with cisplatin resistance in hepatocellular carcinoma cell lines: implications for PEGylated arginine deiminase combination therapy.. BMC Cancer. 14:621.
Howden SE, Thomson JA.  2014.  Gene targeting of human pluripotent stem cells by homologous recombination.. Methods Mol Biol. 1114:37-55.
Belair DG, Whisler JA, Valdez J, Velazquez J, Molenda JA, Vickerman V, Lewis R, Daigh C, Hansen TD, Mann DA et al..  2014.  Human Vascular Tissue Models Formed from Human Induced Pluripotent Stem Cell Derived Endothelial Cells.. Stem Cell Rev.
Capowski EE, Simonett JM, Clark EM, Wright LS, Howden SE, Wallace KA, Petelinsek AM, Pinilla I, M Phillips J, Meyer JS et al..  2014.  Loss of MITF expression during human embryonic stem cell differentiation disrupts retinal pigment epithelium development and optic vesicle cell proliferation.. Hum Mol Genet.
M Phillips J, Perez ET, Martin JM, Reshel ST, Wallace KA, Capowski EE, Singh R, Wright LS, Clark EM, Barney PM et al..  2014.  Modeling human retinal development with patient-specific induced pluripotent stem cells reveals multiple roles for visual system homeobox 2.. Stem Cells. 32(6):1480-92.
Jiang P, Meyer S, Hou Z, Propson NE, H Soh T, Thomson JA, Stewart R.  2014.  MPBind: a Meta-motif-based statistical framework and pipeline to Predict Binding potential of SELEX-derived aptamers.. Bioinformatics. 30(18):2665-7.

Pages